Growth Hormone or Sildenafil as Therapies for Fatigue in Mild- Traumatic-brain-injury (MTBI)
Status:
Completed
Trial end date:
2017-11-10
Target enrollment:
Participant gender:
Summary
The overall goal is to determine whether perceptual or performance fatigue can be reduced in
MTBI patients with and without growth hormone (GH) deficiency by treating them in a crossover
fashion based upon GH status.
A battery of functional, fatigue, cognitive, imaging and blood flow tests will be performed
to assess the efficacy of the two drug interventions, Growth hormone and Sildenafil.